
For individuals with oily, acne-prone skin, the battle often feels like a never-ending war on two fronts. While managing active breakouts and excessive sebum production is a daily struggle, the aftermath—persistent post-acne scarring—presents a long-term challenge that can significantly impact skin texture and confidence. A 2022 study in the Journal of Clinical and Aesthetic Dermatology found that over 40% of individuals with moderate to severe acne develop some degree of atrophic scarring, with oily skin types being particularly susceptible due to prolonged inflammation and impaired wound healing. This creates a frustrating paradox: the very skin condition that causes the scars also makes them notoriously difficult to treat, as many aggressive scar-revision methods can irritate the skin, disrupt the barrier, and trigger new breakouts. This leads to the critical long-tail question for this specific demographic: Can a treatment like rejuran, designed for skin regeneration, effectively remodel stubborn acne scars without clogging pores or exacerbating the underlying oily, breakout-prone condition?
Oily, acne-prone skin operates under a unique set of biological pressures. Hyperactive sebaceous glands produce excess sebum, which can oxidize and mix with dead skin cells, creating an ideal environment for Cutibacterium acnes proliferation. This leads to inflammation, manifesting as papules, pustules, and in severe cases, painful cystic nodules. The body's inflammatory response, while fighting the infection, often damages the collagen and elastin fibers in the dermis. When the acne lesion heals, this damage can result in atrophic scars—depressions in the skin commonly categorized as icepick, boxcar, or rolling scars. The ongoing cycle of oiliness and potential breakouts complicates scar treatment. Introducing new actives or procedures must be done with extreme caution to avoid further inflammation or introducing comedogenic ingredients that could fuel the primary acne condition. The goal is not just to fill a scar, but to do so in a way that respects the skin's reactive nature.
At its core, Rejuran is not a traditional filler. Its primary active ingredient is polynucleotides (PN), which are chains of nucleotides derived from purified salmon DNA. The mechanism of action for Rejuran is a fascinating example of biomimetic repair, functioning through a multi-step process to support the skin's natural healing architecture, which is often deficient in scarred tissue. Here is a text-based diagram of its proposed mechanism:
Clinical data supports this mechanism. A 2019 study published in the Journal of Cosmetic Dermatology evaluated the efficacy of polynucleotide injections for atrophic acne scars. After a series of treatments, researchers observed a statistically significant improvement in scar depth and overall skin smoothness, as measured by objective imaging systems. The study noted that the treatment was well-tolerated. However, the debate for oily, acne-prone skin centers on its use during active inflammation. While Rejuran itself is considered biocompatible and non-immunogenic, injecting any substance into an actively inflamed cystic lesion is contraindicated, as it can worsen the inflammation or lead to infection. The reparative action of Rejuran is best harnessed in a stable, non-inflamed environment.
| Treatment Aspect | Rejuran (Polynucleotide Therapy) | Traditional Hyaluronic Acid (HA) Fillers | Ablative Laser Resurfacing |
|---|---|---|---|
| Primary Mechanism | Stimulates endogenous collagen/elastin production (neocollagenesis). | Physically fills volume deficit with exogenous HA gel. | Removes damaged top layers to trigger controlled wound healing. |
| Ideal Scar Type | Atrophic scars (boxcar, rolling), skin texture irregularities. | Wider, shallower rolling scars with distinct edges. | Various atrophic scars, but technique-dependent. |
| Downtime & Irritation Risk | Minimal; minor redness/swelling for 24-48hrs. Low irritation profile. | Moderate; risk of lumpiness, Tyndall effect, longer swelling. | Significant; open wounds, prolonged redness, high risk of Post-Inflammatory Hyperpigmentation (PIH), especially in darker skin. |
| Impact on Sebum & Acne | Theoretically low; PN is not comedogenic. Risk if injected into active cysts. | Potential risk; HA can attract water, possibly worsening congestion in very oily skin. | High risk; disrupted barrier can lead to rebound oiliness, infection, or acne flare-ups. |
| Result Onset & Longevity | Gradual improvement over 2-3 months as collagen rebuilds. Requires initial series (3-4 sessions), results can last 12-18 months. | Immediate visual filling. Duration varies (6-18 months) as HA metabolizes. | Results appear after healing (weeks to months). Can be long-lasting but may require multiple sessions. |
Success with Rejuran for this skin type is not about the injection alone; it's about integrating it into a holistic, pre-emptive strategy. The treatment plan must be bifurcated: first, achieving and maintaining acne control, and second, strategically deploying Rejuran for scar revision.
Phase 1: Pre-Treatment Acne Stabilization (Critical First Step): A course of Rejuran should only commence when active, inflammatory acne (especially cystic nodules) is under good control. This often involves working with a dermatologist on a regimen that may include topical retinoids, azelaic acid, or oral medications like isotretinoin for severe cases. This phase may take several weeks to months.
Phase 2: The Rejuran Treatment Series: Once the skin is stable, a series of 3 to 4 Rejuran sessions, spaced approximately 4 weeks apart, is typically recommended. The injections are performed using fine needles or cannulas to deliver the polynucleotide solution directly into the scarred areas and the surrounding dermis. For oily skin, some practitioners may combine a Rejuran treatment with a gentle, oil-regulating facial or a superficial chemical peel (like salicylic acid) in the same session, provided the skin's barrier is intact. This addresses surface congestion while Rejuran works on deeper structural repair.
Phase 3: Post-Treatment & Maintenance Care: Aftercare is paramount. A strict non-comedogenic skincare routine is essential. This includes a gentle cleanser, a lightweight, oil-free moisturizer, and broad-spectrum sunscreen daily (as sun exposure can worsen scarring and hyperpigmentation). Continued use of non-irritating acne preventatives like niacinamide or low-strength retinoids can help maintain the clear skin baseline, allowing the benefits of Rejuran to shine through. The longevity of results from a Rejuran series can be extended with proper skincare and possibly annual touch-up sessions.
While Rejuran offers a promising path, it is not a universal solution and carries specific risks for reactive skin types. The most significant contraindication is active, inflamed cystic acne. Injecting into an inflamed lesion can trap bacteria, potentially leading to a more severe infection or a prolonged inflammatory nodule. There is also a noted, though uncommon, risk of developing milia (tiny, white keratin cysts) at the injection site, as the healing process can sometimes accelerate keratinization. This risk may be slightly higher in skin types prone to keratin plugging. A thorough consultation with a dermatologist or licensed practitioner who is experienced in both acne management and regenerative injections like Rejuran is non-negotiable. They must assess the skin's current state, rule out any active infection, and set realistic expectations. As with all aesthetic procedures, individual results from Rejuran can vary based on scar severity, skin biology, and adherence to pre- and post-care protocols.
In conclusion, Rejuran represents a valuable and sophisticated tool in the arsenal against acne scarring for those with oily, acne-prone skin. Its strength lies in its ability to stimulate the skin's innate repair mechanisms from within, improving texture and scar depth without introducing a foreign, permanent filler substance. However, its efficacy and safety are profoundly conditional. The journey must begin with bringing active breakouts under firm control. When timed correctly and administered as part of a comprehensive plan that includes diligent, oil-conscious skincare, Rejuran can help remodel the landscape of scarred skin without reigniting the cycle of breakouts. It shifts the focus from mere camouflage to true biological restoration. For anyone considering this path, the key is patience, professional guidance, and the understanding that treating scars in reactive skin is a marathon, not a sprint. The final outcome hinges on treating both the symptom—the scar—and the underlying skin condition with equal respect and strategy. Specific results and suitability for Rejuran treatment can vary based on individual skin conditions and require professional assessment by a qualified practitioner.